Home/Filings/4/0001209191-23-039420
4//SEC Filing

Robbins Andrew R 4

Accession 0001209191-23-039420

CIK 0001708493other

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 4:38 PM ET

Size

8.7 KB

Accession

0001209191-23-039420

Insider Transaction Report

Form 4
Period: 2023-06-22
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2023-06-22+23,00023,000 total
    Exercise: $0.67Exp: 2033-06-21Common Stock (23,000 underlying)
Footnotes (1)
  • [F1]The stock option will fully vest and become exercisable on June 21, 2024, subject to the continuous service of the Reporting Person with the Issuer on such date.

Issuer

Harpoon Therapeutics, Inc.

CIK 0001708493

Entity typeother

Related Parties

1
  • filerCIK 0001590157

Filing Metadata

Form type
4
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 4:38 PM ET
Size
8.7 KB